Bristol’s 0.02% Decline with $420M Volume Lands 277th in Daily Turnover

Generated by AI AgentAinvest Volume Radar
Tuesday, Sep 16, 2025 7:09 pm ET1min read
Aime RobotAime Summary

- Bristol (BMY) fell 0.02% on 9/16/2025 with $420M volume, ranking 277th in daily turnover.

- Analysts attribute muted trading to lack of near-term catalysts like earnings or regulatory updates.

- Long-term growth focus on oncology/immunology pipelines contrasts with current range-bound stock trajectory.

- Market uncertainty persists until Q4 earnings or partnership announcements provide directional clarity.

On September 16, 2025, , , . The muted performance suggests limited investor activity, with market participants appearing cautious ahead of potential catalysts. The stock’s narrow movement aligns with broader market uncertainty, though no direct corporate developments were reported to influence the session.

Analysts noted that Bristol’s subdued trading environment reflects a lack of near-term catalysts, such as earnings releases or regulatory updates, which typically drive volatility. , but immediate market reaction appears muted. With no material news impacting the sector, .

To run this back-test I need to clarify a couple of practical points: 1. UniverseUPC-- – should I screen only U.S. listed common stocks (i.e., the entire U.S. equity universe), or do you have another market in mind? 2. , ? 3. , or apply a round-trip cost assumption (e.g. ? .

Hunt down the stocks with explosive trading volume.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet